Thanks shareman. That doesn't read like a negative statement to me. It just stated it does not 'support further testing''. Makes sense. The drug is effective for covid. But BIT225 was meant for HIV considering the investment in time and money and the possible partnership with Gilead. Biotron I imagine would rather explore other compounds at the time for covid rather than commit their high end drug, hence other covid-purposed compounds.
My sentiment remains Buy. This new strategic direction to commit BIT225 for covid to expedite FDA approval is a smart move that should have been done early. Its fortuitious that is not late to the party, if anything, makes it valuable.
- Forums
- ASX - By Stock
- BIT
- Ann: Chairman's Address and Presentation to AGM
Ann: Chairman's Address and Presentation to AGM, page-68
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
-0.001(4.35%) |
Mkt cap ! $19.85M |
Open | High | Low | Value | Volume |
2.2¢ | 2.3¢ | 2.1¢ | $5.848K | 265.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1098181 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 97130 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1098181 | 0.021 |
2 | 1031363 | 0.020 |
1 | 225000 | 0.019 |
6 | 491000 | 0.018 |
6 | 725352 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 97130 | 1 |
0.023 | 1449422 | 4 |
0.024 | 500000 | 1 |
0.025 | 223000 | 3 |
0.028 | 95406 | 3 |
Last trade - 15.32pm 17/09/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |